Patent & IP news for November 9, 2012

Patent Litigations

USPTO Stats

5,929
published
appl'ns
5,674
granted
patents
271
ptab
decisions

Patent & IP Blogs

Court Overrules PTO Interpretation of B-Delay Calculation from www.patentdocs.org

By Kevin E. Noonan -- Judge T.S. Ellis III of the U.S. District Court for the Eastern District of Virginia wrote the latest chapter in the story of judicial review of (and, generally, disagreement ...

Share via E–mail | Twitter | Facebook

Accelerated Examination from www.patentlyo.com

By Dennis Crouch The PTO backlog and resulting delays in prosecution is rightfully a common topic of discussion for patent applicants. However, there are also a growing number of patents being issued on a much ...

Share via E–mail | Twitter | Facebook

Patent Litigation Settlement Roundup from www.ipwatchdog.com

On November 8, 2012, Mylan Inc. (Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen ...

Share via E–mail | Twitter | Facebook

UN Joint Inspection Unit Launches New Website from www.ip-watch.org

The only independent external oversight body of the United Nations has launched a new website, making it easier to access its reports dating back to 1968, and other information. Related Articles:

Share via E–mail | Twitter | Facebook

By Dennis Crouch Samsung v. Apple, [2012] EWCA Civ 1430 The concluding line of Sir Robin Jacob's opinion reads as follows: "I hope that the lack of integrity involved in this incident is entirely atypical of Apple." Apart from misleading... from www.patentlyo.com

By Dennis Crouch Samsung v. Apple, [2012] EWCA Civ 1430 The concluding line of Sir Robin Jacob's opinion reads as follows: "I hope that the lack of integrity involved in this incident is entirely ...

Share via E–mail | Twitter | Facebook

Canada’s Top Court Gives Canadians Something to Get Excited About, Generic Viagra! from www.iposgoode.ca

On November 8, 2012 the Supreme Court of Canada (SCC) released its eagerly anticipated decision in the “Viagra Appeal”. In a unanimous decision written by Justice LeBel, the SCC found the patent at issue invalid ...

Share via E–mail | Twitter | Facebook

Daily Ticker Shows Patent Stupidity from hallingblog.com

The Daily Ticker has an article by Henry Blodget, entitled Apple’s New iPad Patent Reveals the Absurdity of Our Patent System.    Mr. Blodget and his guest Alexandre Montagu complain that Apple’s new patent ...

Share via E–mail | Twitter | Facebook

EU Health Cooperation: Room For Improvement from www.ip-watch.org

The European Union’s global plan for health, development cooperation includes the commitment that high-quality medicines and care in the developing world be available without restrictions. As such, despite its growing impact and strong investment ...

Share via E–mail | Twitter | Facebook

Supreme Court Hears Oral Argument in Already LLC v. Nike, Inc. from www.iplawalert.com

On Wednesday, the Supreme Court heard oral argument in the case of Already, LLC d/b/a Yums v. Nike, Inc. As we reported previously, that case arose from an appeal of the Second Circuit ...

Share via E–mail | Twitter | Facebook

Canadian Supreme Court Voids Pfizer’s Viagra Patent – Focusing Disclosure Requirement on the Patent as a Whole from www.patentlyo.com

Teva Canada Ltd. v. Pfizer Canada Inc., 2012 SCC 60 (Supreme Court of Canada 2012) In a November 8, 2012 decision, the Supreme Court of Canada has ruled that Pfizer's Viagra patent is void ...

Share via E–mail | Twitter | Facebook

WHO Negotiations On Global Monitoring Framework Seen As Success in Noncommunicable Disease Fight from www.ip-watch.org

World Health Organization members this week achieved consensus on a set of voluntary targets and indicators for the prevention and control of the world’s biggest killers including cancer, diabetes, cardiovascular and chronic respiratory diseases ...

Share via E–mail | Twitter | Facebook

Study Shows Drug Patents Can Be Extended For Decades from www.ip-watch.org

The industry practice of extending patent protection on pharmaceuticals by obtaining additional patents on other features of the drug ingredients can lead to decades of delay in generic competition, a new study argues. Related Articles ...

Share via E–mail | Twitter | Facebook

ITC Terminates Bond Forfeiture Proceeding In Certain Semiconductor Chips With Minimized Chip Package Size (337-TA-605) from www.itcblog.com

On November 2, 2012, the International Trade Commission (the “Commission”) issued a notice and order granting a joint motion to terminate the bond forfeiture proceeding between Tessera, Inc. (“Tessera”) and Freescale Semiconductor, Inc. (“Freescale”) based ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2014 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.